Michael Melnick

449 total citations
10 papers, 291 citations indexed

About

Michael Melnick is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Michael Melnick has authored 10 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Infectious Diseases. Recurrent topics in Michael Melnick's work include HIV/AIDS drug development and treatment (5 papers), Chemical Synthesis and Analysis (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Michael Melnick is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Chemical Synthesis and Analysis (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Michael Melnick collaborates with scholars based in United States and Canada. Michael Melnick's co-authors include Sandra Lightle, Jeffrey F. Ohren, Laura McDowell, Igor Mochalkin, Krzysztof Appelt, Jay F. Davies, Siegfried Reich, Anthony J. Trippe, Mary Ann M. Fuhry and Lakshmi Narasimhan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

Michael Melnick

9 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Melnick United States 8 181 106 57 39 34 10 291
Larryn W. Peterson United States 12 316 1.7× 118 1.1× 110 1.9× 20 0.5× 19 0.6× 39 498
Neeraj K. Mishra United States 11 390 2.2× 66 0.6× 34 0.6× 53 1.4× 27 0.8× 19 517
Douglas A. Bergman Australia 12 358 2.0× 182 1.7× 83 1.5× 33 0.8× 50 1.5× 15 492
Li Liang China 11 185 1.0× 38 0.4× 70 1.2× 29 0.7× 88 2.6× 38 374
Joseph Rebehmed France 12 287 1.6× 74 0.7× 28 0.5× 80 2.1× 32 0.9× 23 402
Erik C Hansen United States 8 213 1.2× 30 0.3× 47 0.8× 24 0.6× 25 0.7× 11 351
Steven Pratt United Kingdom 12 244 1.3× 163 1.5× 50 0.9× 21 0.5× 9 0.3× 15 473
Jerome C. Bressi United States 10 432 2.4× 158 1.5× 55 1.0× 60 1.5× 41 1.2× 10 582
Evon Winborne United States 9 268 1.5× 91 0.9× 90 1.6× 140 3.6× 33 1.0× 11 482
Christian Studer Switzerland 9 274 1.5× 47 0.4× 51 0.9× 21 0.5× 72 2.1× 13 423

Countries citing papers authored by Michael Melnick

Since Specialization
Citations

This map shows the geographic impact of Michael Melnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Melnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Melnick more than expected).

Fields of papers citing papers by Michael Melnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Melnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Melnick. The network helps show where Michael Melnick may publish in the future.

Co-authorship network of co-authors of Michael Melnick

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Melnick. A scholar is included among the top collaborators of Michael Melnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Melnick. Michael Melnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rodón, Jordi, Matthew H. Taylor, Eileen M. O’Reilly, et al.. (2018). A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors.. Journal of Clinical Oncology. 36(15_suppl). TPS12126–TPS12126. 14 indexed citations
2.
Miller, J. Richard, V. Thanabal, Michael Melnick, et al.. (2010). The Use of Biochemical and Biophysical Tools for Triage of High‐Throughput Screening Hits – A Case Study with Escherichia coli Phosphopantetheine Adenylyltransferase. Chemical Biology & Drug Design. 75(5). 444–454. 24 indexed citations
3.
Mochalkin, Igor, Sandra Lightle, Lakshmi Narasimhan, et al.. (2008). Structure of a small‐molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site. Protein Science. 17(3). 577–582. 43 indexed citations
4.
Mochalkin, Igor, Sandra Lightle, Yaqi Zhu, et al.. (2007). Characterization of substrate binding and catalysis in the potential antibacterial target N‐acetylglucosamine‐1‐phosphate uridyltransferase (GlmU). Protein Science. 16(12). 2657–2666. 37 indexed citations
5.
Bilder, P.W., Sandra Lightle, Graeme Bainbridge, et al.. (2006). The Structure of the Carboxyltransferase Component of Acetyl-CoA Carboxylase Reveals a Zinc-Binding Motif Unique to the Bacterial Enzyme,. Biochemistry. 45(6). 1712–1722. 69 indexed citations
6.
Reich, Siegfried, Michael Melnick, Mary Ann M. Fuhry, et al.. (1996). Structure-Based Design and Synthesis of Substituted 2-Butanols as Nonpeptidic Inhibitors of HIV Protease:  Secondary Amide Series. Journal of Medicinal Chemistry. 39(14). 2781–2794. 38 indexed citations
7.
Melnick, Michael, Siegfried Reich, Anthony J. Trippe, et al.. (1996). Bis Tertiary Amide Inhibitors of the HIV-1 Protease Generated via Protein Structure-Based Iterative Design. Journal of Medicinal Chemistry. 39(14). 2795–2811. 27 indexed citations
8.
Melnick, Michael, Siegfried Reich, Anthony J. Trippe, et al.. (1996). ChemInform Abstract: Bis Tertiary Amide Inhibitors of the HIV‐1 Protease Generated via Protein Structure‐Based Iterative Design.. ChemInform. 27(43).
9.
Reich, Siegfried, Michael Melnick, Mary Ann M. Fuhry, et al.. (1996). ChemInform Abstract: Structure‐Based Design and Synthesis of Substituted 2‐Butanols as Nonpeptidic Inhibitors of HIV Protease: Secondary Amide Series.. ChemInform. 27(43). 1 indexed citations
10.
Reich, Siegfried, Michael Melnick, Jay F. Davies, et al.. (1995). Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.. Proceedings of the National Academy of Sciences. 92(8). 3298–3302. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larryn W. Peterson Breakdown of academic impact, for papers by Neeraj K. Mishra Breakdown of academic impact, for papers by Douglas A. Bergman Breakdown of academic impact, for papers by Li Liang Breakdown of academic impact, for papers by Joseph Rebehmed Breakdown of academic impact, for papers by Erik C Hansen Breakdown of academic impact, for papers by Steven Pratt Breakdown of academic impact, for papers by Jerome C. Bressi Breakdown of academic impact, for papers by Evon Winborne Breakdown of academic impact, for papers by Christian Studer
Rankless by CCL
2026